Shopping Cart (0)
My Account

Shopping Cart
3 for 2 Offer SELECTBIO Conferences Circulating Biomarkers and Extracellular Vesicles Europe 2024Point-of-Care, Biosensors and Rapid Dx Europe 2024Organoids and Spheroids Europe 2024Lab-on-a-Chip and Microfluidics Europe 2024Emerging Technologies for Diagnostics & Liquid Biopsies - New Orleans 2024ePoster Award Prize

Business Courses

Bioprocessing, Biotherapeutics, and Biosimilars: Technical and Commercial Analysis

This Business Course is being held in London, England on the 26 June 2012 at 14.00-16:30


Enal Razvi Image
Enal Razvi
Managing Director,
Select Biosciences Inc

This course is designed to provide a comprehensive discussion of the latest trends in Bioprocessing and Biotherapeutics—both technical and commercial. The focus is on the various classes of protein therapeutics in use today, technologies for production, their production metrics, the emerging biosimilars paradigm, as well as commercial trends [quantitative] and a regulatory analysis of the biosimilars field from both the US and EU perspectives.

This course draws upon primary research data collected by Select Biosciences on bioprocessing/Biotherapeutics, as well as our continual monitoring of the growing biosimilars field.




  • Classes of Biotherapeutics and Market Metrics
  • Production Methodologies
  • Bioprocessing Market Dynamics
  • Growth Opportunities
  • Biosimilars Market Environment
    • Global Ventures, Alliances, Partnerships in this Space
    • US and EU Regulatory Definitions and Guidelines
    • Asia/Pacific

This training course is ideally suited for researchers involved in bioprocessing and bioproduction—both academic as well as from the industrial community. Also, this course is important for biotechnology, pharmaceutical, and related disciplines wherein industry participants—both technically focused as well as business focused—can get a solid understanding of the marketplace as well as receive the most up-to-date market data and associated materials for in-house research and business planning activities.  Also, this course is recommended for investors as well as attorneys looking for a current technology and market review of this expanding field, especially as it relates to biosimilars and the changing US vs. EU paradigms in this area.

All attendees to this training course receive the electronic files of the presentation material on disk with full rights to use them in their internal R&D as well as business planning activities.

Training Course Specific Presentation Topics

  • Classes of Biologics/Biotherapeutics
  • What are the Technical Challenges for Development and Production of Biologics?
  • Market Dynamics of Bioprocessing
  • Growth Opportunities in the Biotherapeutics Space
  • Monoclonal Antibodies, Therapeutics Proteins: Current Market Trends
  • Vaccines
    • Market Analysis
    • Growth Opportunities
    • US vs. EU vs. ROW
  • Biosimilars
    • Current Status of the Field Worldwide
    • Quantitative Market Metrics
    • US vs. EU vs. Asia/Pacific: Opportunities
    • Regulatory Paradigms: US vs. EU
    • Analysis of Alliances and Partnerships

For more information about this training course or for group registrations, please e-mail Kathy Gray at